Pharmaceutical News

RSS

Pew Health Group to ensure safety of U.S. drug supply

On Wednesday, September 14, Allan Coukell, a pharmacist and director of medical programs at the Pew Health Group, will testify before the Senate Health Education Labor and Pensions Committee about the need for Congressional action to ensure the safety of the U.S. drug supply.

12 Sep 2011

General anesthesia can cause cognitive impairment in children

General anesthesia administered to the developing animal brain depresses much needed neuronal activity and communication resulting in long-lasting cognitive impairment, according to an article published in the August issue of Current Opinion in Anesthesiology.

12 Sep 2011

Diamyd receives NIH grant to develop NTDDS for Chemotherapy Induced Peripheral Neuropathy

Diamyd Medical AB with collaborators has received a three million dollar grant from the US National Institutes of Health to develop the Company's patented Nerve Targeting Drug Delivery System (NTDDS) for prevention of Chemotherapy Induced Peripheral Neuropathy.

12 Sep 2011

FDA grants orphan drug designation for Avedro's VibeX to treat Keratoconus

Avedro, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's VibeX for use with its KXL System (UVA irradiation) for Corneal Cross-linking to treat Keratoconus.

12 Sep 2011

PharmAthene completes 1,500 liter engineering production run for SparVax anthrax vaccine

PharmAthene, Inc. announced today that it has achieved significant progress in the development of its second generation anthrax vaccine, SparVax.

12 Sep 2011

Candidate malaria vaccine represents 'potentially encouraging anti-malaria strategy,' researchers say

A team of researchers led by Stephen Hoffman of Sanaria Inc. has created a candidate malaria vaccine against Plasmodium falciparum, the most deadly of the malaria parasites, using live but weakened parasites that "represents a potentially encouraging anti-malaria strategy," an NIH/National Institute of Allergy and Infectious Diseases press release reports.

12 Sep 2011

Access to lifesaving generic medicines threatened by U.S. trade pact

"Access to affordable lifesaving medicines will be threatened where they are needed most -- in parts of the developing world -- if the U.S. insists on implementing restrictive intellectual property policies in the Trans-Pacific Partnership (TPP) trade agreement," states a press release from Doctors Without Borders.

12 Sep 2011

Study pinpoints relationship between primary brain tumors and onset of epileptic seizures

New research from the University of Alabama at Birmingham pinpoints the relationship between primary brain tumors and the onset of epileptic seizures and reveals that a drug used to treat Crohn's disease inhibits those seizures and may be able to slow a tumor's growth.

12 Sep 2011

FDA panel votes 9-2 in favor of new blood thinner drug

A new stroke preventer from Bayer and Johnson & Johnson – Xarelto moved one step closer to U.S. approval, but questions remained about restrictions on labeling and the need for more studies.

9 Sep 2011

HPV vaccination updates

Texas Governor Rick Perry's GOP rivals sharply criticized him during Wednesday night's debate over his 2007 executive order mandating that teenage girls be vaccinated to prevent cervical cancer. The move had drawn strong opposition at the time from social conservatives and was later overturned by the state Legislature.

9 Sep 2011

AstraZeneca Canada introduces new NEXIUM Patient Support program

Canadian pharmaceutical company, AstraZeneca Canada Inc., has introduced a new NEXIUM® Patient Support program designed to give physicians and pharmacists the ability to take cost out of the equation in the patient's choice between NEXIUM® tablets and a generic esomeprazole product.

9 Sep 2011

FDA grants final approval for Mylan's Promethazine HCl Tablets

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Promethazine Hydrochloride (HCl) Tablets USP, 12.5 mg, 25 mg and 50 mg. Promethazine HCl Tablets are used to relieve the symptoms of certain allergic reactions, such as perennial and seasonal allergic rhinitis.

9 Sep 2011

Astex selects PharmaVentures to assist in divesment of CMC & Formulation Facility

PharmaVentures Limited, experts in deals and alliances, are pleased to announce that they have been engaged by leading drug discovery company, Astex Pharmaceuticals to seek a buyer for an established full service CMC & Formulation Facility in Pleasanton, California. The engagement will utilise PharmaVentures' asset divestment expertise in the life sciences sector.

9 Sep 2011

SAMHSA survey finds increase in use of illicit drugs among Americans between 2008-2010

The use of illicit drugs among Americans increased between 2008 and 2010 according to a national survey conducted by the Substance Abuse and Mental Health Services Administration.

9 Sep 2011

Elusys receives federal contract to develop prophylactic treatment against anthrax

Elusys Therapeutics, Inc., a biopharmaceutical company developing biodefense countermeasures, announced today that it has been awarded the first U.S. Government contract to develop an anti-toxin for pre- and post-exposure prophylaxis (PEP) use via intramuscular injection.

9 Sep 2011

Possible link between mother's diet and risk of allergies in children

A possible link between what a mother eats during pregnancy and the risk of her child developing allergies has been identified in new research published in this month's The Journal of Physiology.

9 Sep 2011

Auxilium reports positive data from XIAFLEX retrospective commercial patient chart review

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced that positive data from a retrospective commercial patient chart review of XIAFLEX (collagenase clostridium histolyticum) used for the treatment of adult Dupuytren's contracture patients with a palpable cord are available via e-posters at the American Society for Surgery of the Hand meeting in Las Vegas.

8 Sep 2011

Naturopathic medicine helps reduce doctors' use of prescription drugs

A new survey commissioned by the Canadian College of Naturopathic Medicine reveals that almost half of Ontarians treated by naturopathic doctors report naturopathic medicine has helped reduce their use of prescription drugs.

8 Sep 2011

EC grants orphan drug status for Santen's sirolimus to treat chronic non-infectious uveitis

Santen Inc., the U.S. subsidiary of global ophthalmic pharmaceutical company Santen Pharmaceutical Co., Ltd. today announced the European Commission (EC) has granted orphan drug status for sirolimus (DE-109) for the treatment of chronic non-infectious uveitis.

From Santen Pharmaceutical Co., Ltd. 8 Sep 2011

Researchers uncover new and safe contraceptive pill for women

Oregon Health & Science University researchers have uncovered a new contraceptive that is more focused, safer and, therefore, available for use among a larger population of women.

8 Sep 2011

Pharmaceutical News

Pew Health Group to ensure safety of U.S. drug supply

General anesthesia can cause cognitive impairment in children

Diamyd receives NIH grant to develop NTDDS for Chemotherapy Induced Peripheral Neuropathy

FDA grants orphan drug designation for Avedro's VibeX to treat Keratoconus

PharmAthene completes 1,500 liter engineering production run for SparVax anthrax vaccine

Candidate malaria vaccine represents 'potentially encouraging anti-malaria strategy,' researchers say

Access to lifesaving generic medicines threatened by U.S. trade pact

Study pinpoints relationship between primary brain tumors and onset of epileptic seizures

FDA panel votes 9-2 in favor of new blood thinner drug

HPV vaccination updates

AstraZeneca Canada introduces new NEXIUM Patient Support program

FDA grants final approval for Mylan's Promethazine HCl Tablets

Astex selects PharmaVentures to assist in divesment of CMC & Formulation Facility

SAMHSA survey finds increase in use of illicit drugs among Americans between 2008-2010

Elusys receives federal contract to develop prophylactic treatment against anthrax

Possible link between mother's diet and risk of allergies in children

Auxilium reports positive data from XIAFLEX retrospective commercial patient chart review

Naturopathic medicine helps reduce doctors' use of prescription drugs

EC grants orphan drug status for Santen's sirolimus to treat chronic non-infectious uveitis

Researchers uncover new and safe contraceptive pill for women

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News